Can J Psychiatry

1. BARKER LC, Zaheer J, Wong-Lee R, Kearney H, et al
   Building a Sexual and Reproductive Health Module for Implementation in Early Psychosis Programs: A Co-creation Process: Creation d'un module sur la sante sexuelle et reproductive a mettre en oeuvre dans les programmes d'intervention precoce en cas de
   Can J Psychiatry. 2026 Feb 18:7067437261420713. doi: 10.1177/07067437261420713.
   

   >> Share

   
   

   
   Mol Psychiatry

2. LU ZA, Ploner A, Birgegard A, Landen M, et al
   Leveraging transdiagnostic genetic liability to psychiatric disorders to dissect clinical outcomes of anorexia nervosa.
   Mol Psychiatry. 2025 Sep 23. doi: 10.1038/s41380-025-03264.
   

   >> Share

   
   
3. LAABOUB N, Vandenberghe F, Ansermot N, Piras M, et al
   Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses.
   Mol Psychiatry. 2026;31:1420-1430.
   

   >> Share

   
   

   
   Neuropsychology

4. JANSEN JL, Krabbendam L, Tucha O, Bruggeman R, et al
   Financial competence, situation, and context of people with recent-onset psychosis: A comparison with matched controls and the role of cognition.
   Neuropsychology. 2026 Feb 16. doi: 10.1037/neu0001070.
   

   >> Share

   
   

   
   PLoS One

5. TSEHAY M, Kelkile TS, Fekadu W, Cohen A, et al
   Mapping potential community resources and care pathways for earlier identification and recovery-oriented intervention for people with psychosis in Addis Ababa, Ethiopia.
   PLoS One. 2026;21:e0297891.
   

   >> Share

   
   

   
   Psychiatry Res

6. DOHERTY E, Laighneach A, Casburn M, Quilligan F, et al
   Genetic studies of psychosocial disability establish correlations and causal relationships with neuropsychiatric disorders.
   Psychiatry Res. 2026;358:116963.
   

   >> Share

   
   

   
   Schizophr Res

7. MULLER MK, de Almeida ER, van der Tuin S, Balafas SE, et al
   The association between daily reports of psychotic experiences and life worthiness in early risk stages for psychosis and across gender.
   Schizophr Res. 2026;291:37-56.
   

   >> Share

   
   
8. ULIANA DL, Popa MO, Paradowski M, Elvers KT, et al
   Novel positive allosteric modulators of alpha 5 subunit-containing GABA(A) receptors (alpha5-GABA(A)Rs) reverse the hyperdopaminergic state in a neurodevelopmental model of schizophrenia.
   Schizophr Res. 2026;291:27-36.
   

   >> Share

   
   
9. UHRENHOLT N, Ganeshalingam A, Arnfred S, Gaede P, et al
   Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.
   Schizophr Res. 2026;291:20-26.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share